Pro-apoptotic compounds represent a promising new class of anti-cancer drugs, particularly for solid tumors resistant to classic chemotherapy.
No takes yet. Share an insight, caveat, or question.
Should not yet alter vascular prevention; leaves open net cardiovascular effects of these compounds.
Belcher et al. (2005) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: